Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Gunnar Husebø (Fana, Norway), Gunnar Husebø, Per Bakke, Jon Hardie, Lorena Lerner, Jeno Gyuris, Tomas Eagan. Growth differentiation factor-15 is a predictor for COPD exacerbations and survival. Eur Respir J 2015; 46: Suppl. 59, 623

Member's Comments

No comment yet.

Related content which might interest you: Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD Source: Eur Respir J , 49 (3) 1601298; DOI: 10.1183/13993003.01298-2016 Year: 2017 Biomarkers in COPD- The role of resistin and leptin Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Macrophage migration inhibitory factor (MIF), a biomarker in COPD? Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Main and additional predictors of COPD progression Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Microalbuminuria as a cardiovascular biomarker in patients with COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Potential markers of the progression of CRF in patients with COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Stable state fibrinogen is additive to MR-proADM as a predictor of mortality in COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Factors influencing cognitive function in COPD Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Activin-A expression in COPD exacerbations: Local index of airway inflammation? Preliminary results Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Serum sirtuin-1 is reduced in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Relation of plasma osteopontin levels with the clinical course in patients with COPD Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Associated factors with persistent airflow limitation in asthma in U-BIOPRED Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Lung cancer in patients with COPD: Incidence and predicting factors Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011